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The authors regret that an inaccurate version of Fig. 4 appears in the original article. The correct version of Fig. 4 and its legend appear below.
Figure 4. DCs matured in the presence of Bet.-APE display 
reduced Th1- and increased Th2-polarizing capacity. DCs were 
left untreated or stimulated with Bet.-APE (3 mg/ml) in the pres-
ence or absence of LPS (100 ng/ml). After 24 h DCs were washed 
and cocultured with CD4 CD45RA  allogenic T cells (DC/T cell 
ratio 1:4) that were expanded for 12 d in the presence of IL-2. T cell 
polarization was determined by analyzing intracellular IFN-  and 
IL-4 accumulation via flow cytometry after restimulation with 
PMA and ionomycin in the presence of brefeldin A during the last 
2 h of stimulation. To address, if the Bet.-APE–dependent Th2 po-
larization could be reverted by exogenous IL-12, hrIL-12 (10 ng/ml) 
was added at the beginning of the coculture of Bet.-APE/LPS-
treated DCs and T cells. Representative experiment of n   3–6 
(compare Table I). To explore the role of IL-4 in the Th2 polarization 
induced by Bet.-APE–treated DCs, IL-4–neutralizing antibodies 
(10  g/ml) were added at the beginning of the DC/T cell coculture. 
Representative experiment of n   3.
 
CORRECTION